Shares of Kenvue (KVUE) are trading slightly higher on Monday after Johnson & Johnson (JNJ) announced it would sell its remaining 9.5% stake in the company. ...
) announced it would sell its remaining 9.5% stake in the company. Kenvue will not receive any money from the sale.Let's talk about Ken View now Marine not as the dramatic of a move, but again, a move that is worth noting here up just about a half of a percent now.The company on the move after Johnson and Johnson saying that's going to sell its remaining 9.5% stake in the company just a year after Johnson and Johnson spin off.Ultimately, here in the longer run, we had the stock.
It's important to note that this is not that the company itself can view is not going to get any money from the sale. Warren Buffett's selling stocks like Apple as he sees trouble ahead — but he'll spend if markets crash: elite strategist
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oscar Health, Kenvue, Hims & Hers: Health earnings roundupYahoo Finance Health Reporter Anjalee Khemlani joins Wealth! to analyze this morning's round of earnings out from top health companies, including health...
Read more »
Kenvue to Cut About 4% of Workforce as Services for J&J ExpireKenvue Inc. shares rose after the consumer health company announced plans for a roughly 4% reduction in its global workforce, part of an efficiency plan intended to make it more competitive.
Read more »
Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobsExplore stories from Atlantic Canada.
Read more »
J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s FamilyJohnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies’ baby powders for giving her a fatal cancer in what was the first verdict against the J&J spinoff in a decade-long litigation over the product.
Read more »
Johnson & Johnson advances $6.475-billion settlement of talc cancer lawsuitsCourts have rebuffed J&J’s two previous efforts to resolve the lawsuits through the bankruptcy of the subsidiary created to absorb J&J’s talc liability, LTL Management
Read more »
Johnson & Johnson reports mixed Q1 earnings, narrows guidanceJohnson & Johnson (JNJ) reported a mixed bag of first quarter results, missing revenue estimates but beating on the bottom line. The company's revenue came...
Read more »